Related Experiment Video
Updated: Dec 20, 2025

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
Published on: June 8, 2019
Cancer diagnosis with DNA molecular computation
Chao Zhang1, Yumeng Zhao1, Xuemei Xu1
1Institute of Molecular Medicine, Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine, State Key Laboratory of Oncogenes and Related Genes, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
This study introduces a DNA computing platform for analyzing microRNA (miRNA) profiles in serum for early cancer diagnosis. The novel platform achieved 86.4% accuracy in distinguishing lung cancer patients from healthy individuals.
Area of Science:
- Biotechnology
- Molecular Biology
- Computational Biology
Background:
- Early cancer diagnosis significantly enhances patient survival rates.
- MicroRNA (miRNA) profiles in serum serve as promising biomarkers for cancer detection.
- Current diagnostic methods may lack the speed, cost-effectiveness, or non-invasiveness desired for widespread screening.
Purpose of the Study:
- To develop and validate a DNA molecular computation platform for analyzing serum miRNA profiles for rapid and accurate cancer diagnosis.
- To assess the platform's efficacy in distinguishing cancer patients from healthy individuals using clinical samples.
Main Methods:
- Designed a DNA molecular computation platform for serum miRNA analysis.
- Trained an in silico computational classifier using The Cancer Genome Atlas (TCGA) miRNA data.
- Employed an in situ amplification and transformation method for miRNA enrichment without altering original data.
- Utilized a computationally powerful yet simple molecular implementation scheme based on DNA.
Main Results:
- Successfully diagnosed cancer using clinical serum samples with 86.4% accuracy.
- Tested on 22 participants: 8 healthy individuals and 14 with lung cancer.
- Demonstrated rapid and accurate analysis of miRNA profiles.
Conclusions:
- The developed DNA computational platform enables inexpensive, non-invasive, and rapid disease screening.
- This technology holds potential for cancer classification and monitoring patient progress.
- The platform offers a promising approach for future clinical applications in disease diagnostics.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Survival Analysis
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Cancer

